Predicted protein targets (top 3)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | F10 | P00742 | 18/20 | 0.49 |
| ▸ | MTOR | P42345 | 1/20 | 0.41 |
| ▸ | F9 | P00740 | 1/20 | 0.39 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL5628288 | 1.00 | F10 (0.49) | F10MTORF9 | |
| SCHEMBL5625865 | 0.92 | F10 (0.47) | F10MTOR | |
| SCHEMBL5626255 | 0.92 | F10 (0.47) | F10MTOR | |
| SCHEMBL5624658 | 0.90 | F10 (0.51) | F10MTOR | |
| SCHEMBL5625719 | 0.90 | F10 (0.51) | F10MTOR | |
| SCHEMBL5625364 | 0.90 | F10 (0.42) | F10 | |
| SCHEMBL5625538 | 0.90 | F10 (0.42) | F10 | |
| SCHEMBL5628565 | 0.90 | F10 (0.42) | F10 | |
| SCHEMBL5655015 | 0.90 | F10 (0.42) | F10 | |
| SCHEMBL5627074 | 0.88 | F10 (0.49) | F10MTOR |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20070179122-A1 | Beta-Aminoacid-Derivatives As Factor Xa Inhibitors | SANOFI-AVENTIS DEUTSCHLAND GMBH (DE) | 2007-08-02 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20070179122-A1 | Beta-Aminoacid-Derivatives As Factor Xa Inhibitors | F12, F11, F5 | F10 9/4885MTOR 1916/4885F9 7/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.